venBio Select Advisor

Latest statistics and disclosures from Avoro Capital Advisors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Avoro Capital Advisors

Companies in the Avoro Capital Advisors portfolio as of the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Immunomedics Common (IMMU) 31.7 $2.2B 26M 85.03
Mirati Therapeutics Common (MRTX) 10.2 $721M 4.3M 166.05
Horizon Therapeutics Common (HZNP) 8.4 $594M +27% 7.7M 77.68
Iovance Biotherapeutics Common (IOVA) 4.5 $314M -7% 9.5M 32.92
Ascendis Pharma Sponsored ADR (ASND) 3.9 $278M +2% 1.8M 154.32
Myokardia Common (MYOK) 3.7 $257M 1.9M 136.33
Argenx Se Sponsored ADR (ARGX) 3.4 $237M -6% 903k 262.52
Sarepta Therapeutics Common (SRPT) 3.3 $235M 1.7M 140.43
Arena Pharmaceuticals Common (ARNA) 3.3 $232M +226% 3.1M 74.79
Amicus Therapeutics Common (FOLD) 2.2 $153M 11M 14.12
Acceleron Pharma Common (XLRN) 2.2 $152M +29% 1.4M 112.53
Biomarin Pharmaceutical Common (BMRN) 1.9 $133M -5% 1.8M 76.08
Mersana Therapeutics Common (MRSN) 1.8 $127M +4% 6.8M 18.62
Madrigal Pharmaceuticals Common (MDGL) 1.5 $106M +154% 890k 118.73

Setup an alert

venBio Select Advisor will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Deciphera Pharmaceuticals Common (DCPH) 1.3 $93M -2% 1.8M 51.30
Adaptimmune Therapeutics Sponsored ADR (ADAP) 1.2 $88M +7% 11M 7.98
Karyopharm Therapeutics Common (KPTI) 1.2 $88M -14% 6.0M 14.60
Constellation Pharmaceuticals Common (CNST) 1.2 $87M +6% 4.3M 20.26
Adverum Biotechnologies Common (ADVM) 1.2 $82M +5% 8.0M 10.30
Trillium Therapeutics Common (TRIL) 1.1 $78M +15% 5.5M 14.21
Kura Oncology Common (KURA) 1.1 $75M +131% 2.4M 30.64
Cymabay Therapeutics Common (CBAY) 1.1 $75M +96% 10M 7.24
Uniqure Nv Common (QURE) 0.9 $65M +16% 1.8M 36.83
Pmv Pharmaceuticals Common 0.8 $58M NEW 1.9M 31.12
Relmada Therapeutics Common (RLMD) 0.8 $56M +5% 1.5M 37.62
Iveric Bio Common (ISEE) 0.6 $41M +2% 7.3M 5.64
Athenex Common (ATNX) 0.6 $40M -15% 3.3M 12.10
Marinus Pharmaceuticals Common 0.5 $39M -74% 3.0M 12.85
Xenon Pharmaceuticals Common (XENE) 0.4 $31M 2.8M 11.07
Cue Biopharma Common (CUE) 0.4 $28M 1.9M 15.05
Altimmune Common (ALT) 0.4 $26M NEW 2.0M 13.20
Amarin Corp Sponsored ADR (AMRN) 0.4 $25M +200% 6.0M 4.21
Retrophin Common (RTRX) 0.3 $25M +26% 1.3M 18.46
Relay Therapeutics Common 0.3 $21M NEW 500k 42.59
Avadel Pharmaceuticals Sponsored ADR (AVDL) 0.3 $21M -8% 4.2M 5.04
Rapt Therapeutics Common (RAPT) 0.3 $19M NEW 575k 32.20
Black Diamond Therapeutics Common (BDTX) 0.3 $18M +14% 603k 30.23
Zogenix Common (ZGNX) 0.2 $16M -61% 875k 17.93
Avidity Biosciences Common (RNA) 0.2 $15M -6% 545k 28.15
Therapeutics Acquisition Corp Common 0.2 $14M NEW 1.0M 14.38
Genocea Biosciences Common (GNCA) 0.2 $12M NEW 5.1M 2.29
Iteos Therapeutics Common 0.2 $11M NEW 460k 24.67
Fennec Pharmaceuticals Common (FENC) 0.1 $10M 1.7M 6.06
Bctg Acquisition Corp Common 0.1 $8.7M NEW 800k 10.84
Alimera Sciences Common (ALIM) 0.0 $2.0M 416k 4.86
Kymera Therapeutics Common 0.0 $1.6M NEW 49k 32.31

Past Filings by Avoro Capital Advisors

SEC 13F filings are viewable for Avoro Capital Advisors going back to 2014

View all past filings